HCPCS A2045: Wound productMedicare rate & RVUs in Oklahoma
Reports the Novashield/Novogen wound product by square centimeter when applied during a qualifying wound procedure.
Medicare pays $113.64 for A2045 in the office in Oklahoma (Oklahoma). Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
On this page 9 sections
What A2045 covers
A2045 identifies Novashield/Novogen product used in wound treatment, measured in square centimeters. It represents the material, not the clinician’s wound preparation or application work. Wound care physicians, surgeons, podiatrists, and other practitioners treating acute or chronic wounds may use it in office or facility settings. The product name and surface area distinguish this supply from other wound matrices.
Report A2045 as an add-on only with the primary procedure for the same treatment, and count the product in square centimeters. Documentation should identify the product, wound site and size, and amount used. CMS places payment within the primary procedure’s global period. A2045 is technical-component-only; a separate code covers interpretation. The area of product used does not replace the site and size criteria for selecting the primary procedure.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
A2045 in Oklahoma
| Payment locality | Office | Facility |
|---|---|---|
| Oklahoma | $113.64 | Unavailable |
How the A2045 rate is calculated
Each of A2045’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · A2045
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense3.81
3.81 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
3.8100
Conversion factor
$33.4009
Medicare rate
$127.26
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for A2045
The CMS indicators that decide how A2045 is paid alongside other services.
CMS payment indicators · A2045
Wound product
| Rule | CMS value | What it means |
|---|---|---|
| Global period | ZZZ | Add-on code: falls within the primary procedure’s global period. |
| Multiple procedures | 0 | No multiple-procedure reduction. |
| Bilateral (modifier 50) | 0 | The 150% bilateral adjustment doesn’t apply. |
| Assistant at surgery (80/81/82/AS) | 0 | Not paid without supporting documentation. |
| Co-surgeons (62) | 0 | Not permitted. |
| Team surgery (66) | 0 | Not permitted. |
| Professional/technical | 3 | Technical component only. |
A2045 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- A2046Wound matrix
- A2046 identifies Dermisphere HDRT, not Novashield/Novogen. Choose the product-specific code matching the material used; the shared per-square-centimeter unit does not make the codes interchangeable.
- A2047Wound matrix
- A2047 identifies Lacertamatrix. A2045 is specific to Novashield/Novogen, so select based on the product documented for the wound treatment.
- A2049TheraCor
- A2049 identifies Theracor rather than Novashield/Novogen. Both are measured per square centimeter, but the reported code follows the product used.
A2045 billing questions
What procedure should A2045 be paired with?
Report it only with the primary wound procedure for the same treatment. For skin-substitute application, the primary code is selected according to the treated site and area.
How should the units be counted?
A2045 is measured per square centimeter. Document the amount of Novashield/Novogen product used rather than substituting the wound’s total area for the quantity applied.
Does A2045 include the product application work?
No. A2045 identifies the product; the primary procedure represents the wound treatment or application service.
Is interpretation included in A2045?
No. CMS classifies A2045 as technical-component-only, with interpretation covered by a separate code.
What documentation supports reporting A2045?
Record the Novashield/Novogen product, wound location and size, quantity used in square centimeters, and the associated primary procedure.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets
Put A2045 and the rest of your codes on one sheet
Build a fee sheet from your own code list at your locality, put your payer contracts beside Medicare, and see what changed each quarter.
Build my fee sheetOr price your code list free →